Theratechnologies Inc. - Common Shares (THTX) analyst actions
Rating and price-target actions on THTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the THTX overview →
1 measured THTX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer | Press release | +0.82% | +3.28% |
Keep exploring
More THTX: earnings → · SEC filings → · THTX overview →